Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial (Q70588153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

placebo-controlled trial

1 reference

1 reference

1 reference

1 reference

Janssen HL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Berk L

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Heijtink RA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

ten Kate FJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Schalm SW

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

language of work or name

English

0 references

publication date

1 March 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

383-388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Zidovudine inhibits hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

A modified technique for the detection of hepatitis B virus-specific DNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Seizures associated with low-dose alpha-interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Inhibition of hepatitis B virus DNA polymerase by 3'-azido-3'-deoxythymidine triphosphate but not by its threo analog

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Effect of 3'-azido-3'-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Treatment of patients with chronic type B hepatitis and concurrent human immunodeficiency virus infection with a combination of interferon alpha and azidothymidine: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Pharmacokinetics of zidovudine in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840170306

7 January 2021

Identifiers

DOI

10.1002/HEP.1840170306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8444411%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference